Efficacy of Levofloxacin Based Triple and High-Dose PPI-Amoxicillin Dual Eradication Therapy for Helicobacter pylori after Failures of First- and Second-Line Therapies (original ) (raw )A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses
Enzo Ierardi
Alimentary Pharmacology and Therapeutics, 2005
View PDFchevron_right
Second-line treatment for failure to eradicate Helicobacter pylori: a randomized trial comparing four treatment strategies
JD J D de Korwin
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy
Virginia Festa
Alimentary Pharmacology and Therapeutics, 2001
View PDFchevron_right
Comparison of efficacies of dual therapy and triple therapy using rabeprazole in second-line eradication of Helicobacter pylori in Japan
Emiko Rimbara
Alimentary Pharmacology & Therapeutics, 2007
View PDFchevron_right
To compare efficacy of 10-day sequential triple therapy versus 14-days sequential therapy for the eradication of H. pylori
Dr. Ns Neki
International Journal of Current Research in Medical Sciences, 2017
View PDFchevron_right
A comparison of 5 or 7 days of rabeprazole triple therapy for eradication of Helicobacter pylori
Murdani Abdullah
Medical Journal of Indonesia, 2010
View PDFchevron_right
Second-Line Levofloxacin-Based Triple Therapy's Efficiency for Helicobacter pylori Eradication in Patients With Peptic Ulcer
Filiz Akyüz
Southern Medical Journal, 2011
View PDFchevron_right
A randomized comparison of quadruple and triple therapies for Helicobacter pylori eradication: The QUADRATE study
Brendan Crotty
Gastroenterology, 2002
View PDFchevron_right
Maedica-a Journal of Clinical Medicine A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori Infection A COMPARATIVE STUDY OF EFFICACY AND SAFETY OF TWO ERADICATION REGIMENS FOR HELICOBACTER PYLORI INFECTION
Carmen Preda
2017
View PDFchevron_right
Rabeprazole-based therapies in Helicobacter pylori eradication
Xavier Calvet
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
A systematic review of Helicobacter pylori eradication therapy-the impact of antimicrobial resistance on eradication rates
Martin Houben
Aliment Pharmacol Therapeut, 1999
View PDFchevron_right
Efficacy and Tolerability of Three Regimens for Helicobacter pylori Eradication: A Multicentre, Double-Blind, Randomised Clinical Trial
Arturo Fueyo
Clinical Drug Investigation, 2001
View PDFchevron_right
Rabeprazole, clarithromycin, and amoxicillin Helicobacter pylori eradication therapy: Report of an efficacy study
R. Igetei , Stella Smith
World Journal of Gastroenterology, 2014
View PDFchevron_right
A Comparative Study of Efficacy and Safety of Two Eradication Regimens for Helicobacter pylori Infection
Carmen Preda
Maedica, 2017
View PDFchevron_right
Helicobacter pylori Eradication Therapy Success Regarding Different Treatment Period Based on Clarithromycin or Metronidazole Triple-Therapy Regimens
Smilja Kalenic
Helicobacter, 2009
View PDFchevron_right
The <i>Helicobacter pylori</i> Eradication Rate in a High Prevalence Area (West Africa): Three Triple Therapy Comparative Study
Alassan Mahassadi
Open Journal of Gastroenterology, 2015
View PDFchevron_right
Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second-line
Lucia Fini
World Journal of Gastroenterology, 2012
View PDFchevron_right
Randomized study of different 'second-line' therapies for Helicobacter pylori infection after failure of the standard 'Maastricht triple therapy
Virginia Festa
Alimentary Pharmacology and Therapeutics, 2003
View PDFchevron_right
A Randomized Study Comparing Levofloxacin, Omeprazole, Nitazoxanide, and Doxycycline versus Triple Therapy for the Eradication of Helicobacter pylori
Niraj Shah
The American Journal of Gastroenterology, 2011
View PDFchevron_right
Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure
Pasquale Berloco
Alimentary Pharmacology and Therapeutics, 2004
View PDFchevron_right
Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial
Jawtown Lin
Journal of Antimicrobial Chemotherapy, 2011
View PDFchevron_right
A randomized controlled comparison of three quadruple therapy regimens in a population with low Helicobacter pylori eradication rates
Mohammed Fazel
Journal of Gastroenterology and Hepatology, 2001
View PDFchevron_right
The <i>Helicobacter pylori</i> Eradication Rate in a High Prevalence Area (West Africa): Three Triple Therapy Comparative Study
Aboubacar Demba Bangoura
Open Journal of Gastroenterology, 2015
View PDFchevron_right
A Randomized Clinical Trial to Determine the Efficacy of Regimens Containing Clarithromycin, Metronidazole, and Amoxicillin Among Histologic Subgroups for Helicobacter pylori Eradication in a Developing Country
Juan Jimenez Bravo
Helicobacter, 2009
View PDFchevron_right
Levofloxacin+Tetracycline Quadruple Regimen for Eradication of Helicobacter pylori : A Multicenter Multinational Randomized Controlled Trial
Eman abdelsameea
Middle East Journal of Digestive Diseases, 2023
View PDFchevron_right
First- and second-line Helicobacter pylori eradication with modified sequential therapy and modified levofloxacin-amoxicillin-based triple therapy
Cesare Efrati , Lorenzo Ridola , Domenico Alvaro
Annals of gastroenterology : quarterly publication of the Hellenic Society of Gastroenterology, 2014
View PDFchevron_right
Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
Rejane Mattar , Ana Cristina S Teixeira
Gastroenterology Research and Practice, 2015
View PDFchevron_right